| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |